Scientists challenged ventricular cardiomyocytes with epidermal growth factor (EGF)-like ligands and observed that selective activation of ErbB4 (the receptor for neuregulin 1), but not ErbB1 (the receptor for EGF), stimulated hypertrophy.
[Journal of Cellular Physiology]
7992332
{7992332:PGIZHUA4}
apa
50
1
163927
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/